A systematic literature review of cardiovascular event utilities

References

• World Health Organization (WHO). Global Status Report on Noncommunicable Diseases 2010. World Health Organization, Geneva, Switzerland (2011).
   Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 125(1), e2–e220 (2012).
   PubMed Web of Science ®Google Scholar
• European Heart Network and European Society of Cardiology. European Cardiovascular Disease Statistics: 2012 edition. Health Economics Research Centre/Department of Public Health, University of Oxford, UK (2012).
   Google Scholar
• Gandhi SK, Jensen MM, Fox KM, Smolen L, Olsson AG, Paulsson T. Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a swedish population at high risk of cardiovascular events. Clin. Econ. Outcomes Res. 4(1), 1–11 (2012).
   Google Scholar
• Catala-Lopez F, Garcia-Altes A, Alvarez-Martin E, Genova-Maleras R, Morant-Ginestar C, Parada A. Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters? BMC Health Serv. Res. 11, 75 (2011).
   Google Scholar
• Grigorov E, Naseva E, Getov I. Study of patients' Willingness-to-Pay for Pharmacotherapy for Ischemic Heart Disease. Arch. Balkan Medical Union 46(3), 177–179 (2011).
   Google Scholar
• Braithwaite RS, Mentor SM. Identifying favorable-value cardiovascular health services. Am. J. Manag. Care 17(6), 431–438 (2011).
   Google Scholar
• Torrance GW. Measurement of health state utilities for economic appraisal. J. Health Econ. 5(1), 1–30 (1986).
   PubMed Web of Science ®Google Scholar
• Torrance GW. Designing and Conducting Cost-Utility Analyses. In: Quality of Life and Pharmacoeconomics in Clinical Trials. Spilker, B ( Ed.). Lippincott-Raven Publishers, Philadelphia, PA, USA (1996)
   Google Scholar
• Feeny D, Barr RD, Furlong W, Torrance GW, Weitzman S. Quality of life of the treatment process in pediatric oncology: an approach to measurement. In: Effect of Cancer on Quality of Life. Osaba, D ( Ed.). CRC Press, FL, USA (1991)
   Google Scholar
• Torrance GW, Furlong W, Feeny D. Health utility estimation. Expert Rev. Pharmacoecon. Outcomes Res. 2(2), 99–108 (2002).
   PubMedGoogle Scholar
• Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 2(2), 113–127 (1999).
   PubMedGoogle Scholar
• Patrick DL, Chiang YP. Measurement of health outcomes in treatment effectiveness evaluations: conceptual and methodological challenges. Med. Care 38(9 Suppl), II14–25 (2000).
   Google Scholar
• Hallan S, Asberg A, Indredavik B, Wideroe TE. Quality of life after cerebrovascular stroke: a systematic study of patients' preferences for different functional outcomes. J. Intern. Med. 246(3), 309–316 (1999).
   PubMed Web of Science ®Google Scholar
• Slot KB, Berge E. Thrombolytic treatment for stroke: patient preferences for treatment, information, and involvement. J. Stroke Cerebrovasc. Dis. 18(1), 17–22 (2009).
   Google Scholar
• Brazier JE, Ratcliffe J, Salomon J, et al. Measuring and Valuing Health Benefits for Economic Evaluation. Oxford University Press, Oxford, UK (2007).
   Google Scholar
• Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann. Med. 33(5), 375–384 (2001).
   PubMed Web of Science ®Google Scholar
• Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual. Life Outcomes 1, 54 (2003).
   PubMedGoogle Scholar
• Bharmal M, Thomas J, 3rd. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health 9(4), 262–271 (2006).
   PubMed Web of Science ®Google Scholar
• Adams J, Lee J, Gonzalo F. Deriving utility values from the general population for dronedarone in the treatment of atrial fibrillation. Value Health 14(7), A384 (2011).
   Google Scholar
• Baeten SA, van Exel NJA, Dirks M, Koopmanschap MA, Dippel DWJ, Niessen LW. Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach. Cost Eff. Resour. Alloc. 8, 21 (2010).
   PubMedGoogle Scholar
• Baker R, Robinson A. Responses to standard gambles: are preferences 'well constructed'? Health Econ. 13(1), 37–48 (2004).
   Google Scholar
• Bowen A, Hesketh A, Patchick E et al. Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT noW study). Health Technol. Assess. 16(26), 1–159 (2012).
   PubMed Web of Science ®Google Scholar
• Chaiyawat P, Kulkantrakorn K. Effectiveness of home rehabilitation program for ischemic stroke upon disability and quality of life: A randomized controlled trial. Clin. Neurol. Neurosurg. 114(7), 866–870 (2012).
   PubMed Web of Science ®Google Scholar
• Christensen MC, Mayer S, Ferran JM. Quality of life after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke 40(5), 1677–1682 (2009).
   Google Scholar
• Cup EH, Scholte op Reimer WJ, Thijssen MC, van Kuyk-Minis MA. Reliability and validity of the Canadian Occupational Performance Measure in stroke patients. Clin. Rehabil. 17(4), 402–409 (2003).
   PubMed Web of Science ®Google Scholar
• Darlington AS, Dippel DW, Ribbers GM, van Balen R, Passchier J, Busschbach JJ. Coping strategies as determinants of quality of life in stroke patients: a longitudinal study. Cerebrovasc. Dis. 23(5–6), 401–407 (2007).
   Google Scholar
• Darlington AS, Dippel DW, Ribbers GM, van Balen R, Passchier J, Busschbach JJ. A prospective study on coping strategies and quality of life in patients after stroke, assessing prognostic relationships and estimates of cost-effectiveness. J. Rehabil. Med. 41(4), 237–241 (2009).
   PubMed Web of Science ®Google Scholar
• Dorman P, Dennis M, Sandercock P. Are the modified “simple questions” a valid and reliable measure of health related quality of life after stroke? United Kingdom Collaborators in the International Stroke Trial. J. Neurol. Neurosurg. Psychiatry 69(4), 487–493 (2000).
   Google Scholar
• Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch. Intern. Med. 156(16), 1829–1836 (1996).
   PubMed Web of Science ®Google Scholar
• Gore JM, Granger CB, Simoons ML et al. Stroke after thrombolysis: Mortality and functional outcomes in the GUSTO- I trial. Circulation 92(10), 2811–2818 (1995).
   Google Scholar
• Grenthe Olsson B, Sunnerhagen KS. Effects of Day Hospital Rehabilitation After Stroke. J. Stroke Cerebrovasc. Dis. 15(3), 106–113 (2006).
   Google Scholar
• Grenthe Olsson B, Sunnerhagen KS. Functional and cognitive capacity and health-related quality of life 2 years after day hospital rehabilitation for stroke: a prospective study. J. Stroke Cerebrovasc. Dis. 16(5), 208–215 (2007).
   Google Scholar
• Haacke C, Althaus A, Spottke A, Siebert U, Back T, Dodel R. Long-term outcome after stroke: evaluating health-related quality of life using utility measurements. Stroke 37(1), 193–198 (2006).
   PubMed Web of Science ®Google Scholar
• Kang EJ, Ko SK. A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. Value Health, 12( Suppl. 3), S114–S117 (2009).
   Google Scholar
• Lai SM, Duncan PW. Stroke recovery profile and the Modified Rankin assessment. Neuroepidemiology 20(1), 26–30 (2001).
   Google Scholar
• Lee HY, Hwang JS, Jeng JS, Wang JD. Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up. Stroke 41(4), 739–744 (2010).
   PubMed Web of Science ®Google Scholar
• Leeds L, Meara J, Hobson P. The impact of discharge to a care home on longer term stroke outcomes. Clin. Rehabil. 18(8), 924–928 (2004).
   Google Scholar
• Lindgren P, Glader EL, Jonsson B. Utility loss and indirect costs after stroke in Sweden. Eur. J. Cardiovasc. Prev. Rehabil. 15(2), 230–233 (2008).
   PubMedGoogle Scholar
• Lindgren P, Kahan T, Poulter N et al. Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy. Eur. J. Health Econ. 8(1), 25–30 (2007).
   PubMed Web of Science ®Google Scholar
• Lunde L. Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients. Eur. J. Health Econ. 1–12 (2012).
   Google Scholar
• MacLean S, Mulla S, Akl EA et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl), e1S–e23S (2012).
   Google Scholar
• Mathias SD, Bates MM, Pasta DJ, Cisternas MG, Feeny D, Patrick DL. Use of the Health Utilities Index with stroke patients and their caregivers. Stroke 28(10), 1888–1894 (1997).
   PubMed Web of Science ®Google Scholar
• Mittmann N, Chan D, Trakas K, Risebrough N. Health utility attributes for chronic conditions. Dis. Manag. Health Outcomes 9(1), 11–21 (2001).
   Google Scholar
• Mittmann N, Trakas K, Risebrough N, Liu BA. Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics 15(4), 369–376 (1999).
   PubMed Web of Science ®Google Scholar
• Murphy R, Sackley CM, Miller P, Harwood RH. Effect of experience of severe stroke on subjective valuations of quality of life after stroke. J. Neurol. Neurosurg. Psychiatry 70(5), 679–681 (2001).
   Google Scholar
• Pettersson I, Ahlstrom G, Tornquist K. The value of an outdoor powered wheelchair with regard to the quality of life of persons with stroke: a follow-up study. Assist. Technol. 19(3), 143–153 (2007).
   PubMed Web of Science ®Google Scholar
• Pickard AS, Johnson JA, Feeny DH. Responsiveness of generic health-related quality of life measures in stroke. Qual. Life Res. 14(1), 207–219 (2005).
   PubMed Web of Science ®Google Scholar
• Pickard AS, Johnson JA, Feeny DH, Shuaib A, Carriere KC, Nasser AM. Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index. Stroke 35(2), 607–612 (2004).
   PubMed Web of Science ®Google Scholar
• Pinto EB, Maso I, Pereira JL et al. Differential aspects of stroke and congestive heart failure in quality of life reduction: a case series with three comparison groups. Health. Qual. Life Outcomes 9, 65 (2011).
   Google Scholar
• Post PN, Stiggelbout AM, Wakker PP. The utility of health states after stroke: a systematic review of the literature. Stroke 32(6), 1425–1429 (2001).
   PubMed Web of Science ®Google Scholar
• Robinson A, Thomson R, Parkin D, Sudlow M, Eccles M. How patients with atrial fibrillation value different health outcomes: a standard gamble study. J. Health Serv. Res. Policy 6(2), 92–98 (2001).
   PubMedGoogle Scholar
• Ryan T, Enderby P, Rigby AS. A randomized controlled trial to evaluate intensity of community-based rehabilitation provision following stroke or hip fracture in old age. Clin. Rehabil. 20(2), 123–131 (2006).
   PubMed Web of Science ®Google Scholar
• Samsa GP, Matchar DB, Goldstein L et al. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am. Heart J. 136(4 Pt 1), 703–713 (1998).
   Google Scholar
• Shin AY, Porter PJ, Wallace MC, Naglie G. Quality of life of stroke in younger individuals: Utility assessment in patients with arteriovenous malformations. Stroke 28(12), 2395–2399 (1997).
   PubMed Web of Science ®Google Scholar
• Sturm JW, Donnan GA, Dewey HM et al. Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 35(10), 2340–2345 (2004).
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan V. Preference-Based EQ-5D index scores for chronic conditions in the United States. Med. Decis. Making 26(4), 410–420 (2006).
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D scores for the United Kingdom. Med. Decis. Making 31(6), 800–804 (2011).
   PubMed Web of Science ®Google Scholar
• Tengs TO, Lin TH. A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics 21(3), 191–200 (2003).
   PubMed Web of Science ®Google Scholar
• Tengs TO, Yu M, Luistro E. Health-related quality of life after stroke a comprehensive review. Stroke 32(4), 964–972 (2001).
   Google Scholar
• van Exel NJ, Scholte op Reimer WJ, Koopmanschap MA. Assessment of post-stroke quality of life in cost-effectiveness studies: the usefulness of the Barthel Index and the EuroQoL-5D. Qual. Life Res. 13(2), 427–433 (2004).
   Google Scholar
• van Wijk I, Gorter JW, Lindeman E et al. Mental status and health-related quality of life in an elderly population 15 years after limited cerebral ischaemia. J. Neurol. 254(8), 1018–1025 (2007).
   Google Scholar
• Wannasiri Y, Kapol N. Measuring health utility in Thai stroke patients. Value Health 14(7), A384 (2011).
   Google Scholar
• Warren JA, Jordan WD, Jr., Heudebert GR, Whitley D, Wirthlin DJ. Determining patient preference for treatment of extracranial carotid artery stenosis: carotid angioplasty and stenting versus carotid endarterectomy. Ann. Vasc. Surg. 17(1), 15–21 (2003).
   Google Scholar
• Wilson ECF, Ford GA, Robinson T, Mistri A, Jagger C, Potter JF. Controlling hypertension immediately post stroke: A cost utility analysis of a pilot randomised controlled trial. Cost Effectiveness and Resource Allocation 8 (2010).
   Google Scholar
• Wissel J, Schelosky LD, Scott J, Christe W, Faiss JH, Mueller J. Early development of spasticity following stroke: a prospective, observational trial. J. Neurol. 257(7), 1067–1072 (2010).
   PubMed Web of Science ®Google Scholar
• Xie J, Wu EQ, Zheng ZJ et al. Impact of stroke on health-related quality of life in the noninstitutionalized population in the United States. Stroke 37(10), 2567–2572 (2006).
   PubMed Web of Science ®Google Scholar
• Yeates A, Mundy J, Griffin R et al. Early and mid-term outcomes following surgical management of infective endocarditis with associated cerebral complications: a single centre experience. Heart Lung Circ. 19(9), 523–527 (2010).
   Google Scholar
• Noto S, Uemura T, Izumi R, Moriwaki K. Construct validity of health utilities index (HUI) Japanese version: Cross-sectional study for stroke in Japan. Value Health 14(3), A45 (2011).
   Google Scholar
• Bradley CJ, Kroll J, Holmes-Rovner M. The health and activities limitation index in patients with acute myocardial infarction. J. Clin. Epidemiol. 53(6), 555–562 (2000).
   Google Scholar
• Glasziou PP, Bromwich S, Simes RJ. Quality of life six months after myocardial infarction treated with thrombolytic therapy. AUS-TASK Group. Australian arm of International tPA/SK Mortality Trial. Med. J. Aust. 161(9), 532–536 (1994).
   Google Scholar
• Huang DT, Sesselberg HW, McNitt S et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J. Cardiovasc. Electrophysiol.18(8), 833–838 (2007).
   PubMedGoogle Scholar
• Kim J, Henderson RA, Pocock SJ et al. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3). J. Am. Coll. Cardiol. 45(2), 221–228 (2005).
   Google Scholar
• Lacey EA, Musgrave RJ, Freeman JV, Tod AM, Scott P. Psychological morbidity after myocardial infarction in an area of deprivation in the UK: evaluation of a self-help package. Eur. J. Cardiovasc. Nurs. 3(3), 219–224 (2004).
   Google Scholar
• Lacey EA, Walters SJ. Continuing inequality: gender and social class influences on self perceived health after a heart attack. J. Epidemiol. Community Health 57(8), 622–627 (2003).
   PubMed Web of Science ®Google Scholar
• Lyerly AD, Myers ER, Faden RR. The ethics of aggregation and hormone replacement therapy. Health Care Anal. 9(2), 187–211 (2001).
   Google Scholar
• Luo X, Cappelleri JC, Chandran A. The Burden of Fibromyalgia: Assessment of Health Status Using the EuroQol (EQ-5D) in Patients with Fibromyalgia Relative to Other Chronic Conditions. Health Outcomes Res. Med. 2(4), e203–e214 (2011).
   Google Scholar
• Nowels D, McGloin J, Westfall JM, Holcomb S. Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Qual. Life Res. 14(1), 95–105 (2005).
   PubMed Web of Science ®Google Scholar
• Pettersen KI, Kvan E, Rollag A, Stavem K, Reikvam A. Health-related quality of life after myocardial infarction is associated with level of left ventricular ejection fraction. BMC Cardiovasc. Disord. 8, 28 (2008).
   PubMed Web of Science ®Google Scholar
• Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart 92(1), 62–67 (2006).
   Google Scholar
• Schweikert B, Hunger M, Meisinger C, Konig HH, Gapp O, Holle R. Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population. Eur. Heart J. 30(4), 436–443 (2009).
   Google Scholar
• Shah P, Najafi AH, Panza JA, Cooper HA. Outcomes and quality of life in patients>or=85 years of age with ST-elevation myocardial infarction. Am. J. Cardiol. 103(2), 170–174 (2009).
   Google Scholar
• Tsevat J, Goldman L, Soukup JR et al. Stability of time-tradeoff utilities in survivors of myocardial infarction. Med. Decis. Making 13(2), 161–165 (1993).
   PubMed Web of Science ®Google Scholar
• Winkelmayer WC, Benner JS, Glynn RJ et al. Assessing health state utilities in elderly patients at cardiovascular risk. Med. Decis. Making 26(3), 247–254 (2006).
   Google Scholar
• Arnold SV, Morrow DA, Wang K et al. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial. Circ. Cardiovasc. Qual. Outcomes 1(2), 107–115 (2008).
   Google Scholar
• Burstrom K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual. Life Res. 10(7), 621–635 (2001).
   PubMed Web of Science ®Google Scholar
• Chong CA, Li S, Nguyen GC et al. Health-state utilities in a prisoner population: a cross-sectional survey. Health. Qual. Life Outcomes 7, 78 (2009).
   Google Scholar
• Goodacre S, Nicholl J, Dixon S et al. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ 328(7434), 254 (2004).
   Google Scholar
• Lalonde L, Clarke AE, Joseph L et al. Conventional and chained standard gambles in the assessment of coronary heart disease prevention and treatment. Med. Decis. Making 19(2), 149–156 (1999).
   Google Scholar
• Lenzen M, Scholte op Reimer W, Norekval TM et al. Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary Revascularization. Eur. J. Cardiovasc. Nurs. 5(2), 115–121 (2006).
   Google Scholar
• Lenzen MJ, Scholte op Reimer WJ, Pedersen SS et al. The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation. Heart 93(3), 339–344 (2007).
   Google Scholar
• Longworth L, Buxton MJ, Sculpher M, Smith DH. Estimating utility data from clinical indicators for patients with stable angina. Eur. J. Health Econ. 6(4), 347–353 (2005).
   Google Scholar
• Manson SC, Van Hanswijck De Jonge P, Palsgrove A, Gorelick PB. Valuation of health state utilities related to cardiovascular prevention with aspirin. Value Health 13(7), A361 (2010).
   Google Scholar
• Nease RF, Jr., Kneeland T, O'Connor GT et al. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. JAMA 273(15), 1185–1190 (1995).
   PubMed Web of Science ®Google Scholar
• Nease RF, Whitcup SM, Ellwein LB, Fox G, Littenberg B. Utility-based estimates of the relative morbidity of visual impairment and angina. Ophthalmic Epidemiol. 7(3), 169–185 (2000).
   PubMedGoogle Scholar
• Nichol G, Llewellyn-Thomas HA, Thiel EC, Naylor CD. The relationship between cardiac functional capacity and patients' symptom-specific utilities for angina: some findings and methodologic lessons. Med. Decis. Making 16(1), 78–85 (1996).
   Google Scholar
• Serruys PW, Unger F, Sousa JE et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N. Engl J. Med. 344(15), 1117–1124 (2001).
   PubMed Web of Science ®Google Scholar
• Weintraub WS, Boden WE, Zhang Z et al. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ. Cardiovasc. Qual. Outcomes 1(1), 12–20 (2008).
   PubMed Web of Science ®Google Scholar
• Werdan K, Ebelt H. Ivabradine in combination with beta-blockers improves symptoms and quality of life in patients with stable angina: Results from the ADDITIONS-study. Eur. Heart J. 32, 340 (2011).
   Google Scholar
• Werdan K, Ebelt H, Nuding S, Hopfner F, Hack G, Muller-Werdan U. Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: Results from the ADDITIONS study. Clin. Res. Cardiol. 101(5), 365–373 (2012).
   PubMed Web of Science ®Google Scholar
• Ammer M, Paget MA, Hronkova M, Norrbacka K, Eber B. Practice patterns and quality of life in acute coronary syndrome patients in 2008-2009: Baseline results for Austria from the antiplatelet treatment observational registry ii (Aptor II). Value Health 13(7), A365 (2010).
   Google Scholar
• Ascione R, Reeves BC, Taylor FC, Seehra HK, Angelini GD. Beating heart against cardioplegic arrest studies (BHACAS 1 and 2): quality of life at mid-term follow-up in two randomised controlled trials. Eur. Heart J. 25(9), 765–770 (2004).
   Google Scholar
• Bakhai A, Ferrieres J, Iniguez A et al. Clinical outcomes, resource use, and costs at 1 year in patients with acute coronary syndrome undergoing PCI: results from the multinational APTOR registry. J. Interv. Cardiol. 25(1), 19–27 (2012).
   Google Scholar
• Bosch JL, van der Graaf Y, Hunink MG. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation 99(24), 3155–3160 (1999).
   Google Scholar
• Brunner-La Rocca HP, Kaiser C, Bernheim A et al. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): an 18-month analysis. Lancet 370(9598), 1552–1559 (2007).
   Google Scholar
• Chaudhury S, Sharma S, Pawar AA et al. Psychological correlates of outcome after coronary artery bypass graft. Medical Journal Armed Forces India 62(3), 220–223 (2006).
   Google Scholar
• Denvir MA, Lee AJ, Rysdale J et al. Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention. J. Epidemiol. Community Health 60(12), 1085–1088 (2006).
   Google Scholar
• Dominiak MT, Krawczyk M, Kurpesa M, Rechcinski T, Kasprzak JD. Early rehabilitation in acute coronary syndrome patients improves self-assessing quality of life but not depression status. Eur. Heart J. 32, 388–389 (2011).
   Google Scholar
• Dunning J, Waller JR, Smith B, Pitts S, Kendall SW, Khan K. Coronary artery bypass grafting is associated with excellent long-term survival and quality of life: a prospective cohort study. Ann. Thorac. Surg. 85(6), 1988–1993 (2008).
   Google Scholar
• Egberg L, Mattiasson AC, Ljungstrom KG, Styrud J. Health-related quality of life in patients with peripheral arterial disease undergoing percutaneous transluminal angioplasty: a prospective one-year follow-up. J. Vasc. Nurs. 28(2), 72–77 (2010).
   Google Scholar
• Fairbairn TA, Mather AN, Bijsterveld P et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 98(1), 18–23 (2012).
   PubMed Web of Science ®Google Scholar
• Hatoum HT, Brazier JE, Akhras KS. Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. Value Health 7(5), 602–609 (2004).
   Google Scholar
• Houlind K, Kjeldsen BJ, Madsen SN et al. On-pump versus off-pump coronary artery bypass surgery in elderly patients: results from the Danish on-pump versus off-pump randomization study. Circulation 125(20), 2431–2439 (2012).
   Web of Science ®Google Scholar
• Kim HS, Tahk SJ, Oh JJ, Ko SK, Ham GR, Lee YS. Health-related quality of life after percutaneous coronary intervention in patients with acute coronary syndromes. Value Health 13(7), A521 (2010).
   Google Scholar
• Lee V, Yan B, Chan T, Woo A, Lee KK, Yu CM. Outcome study of drug eluting stent (DES) versus bare metal stent (BMS) in Hong Kong: a 6-month pilot study. Value Health 14(3), A79–A80 (2011).
   Google Scholar
• Leslie SJ, Rysdale J, Lee AJ et al. Unemployment and deprivation are associated with a poorer outcome following percutaneous coronary angioplasty. Int. J. Cardiol. 122(2), 168–169 (2007).
   Google Scholar
• Mark DB, David Knight J, Velazquez EJ et al. Surgical treatment of ischemic heart failure trial. J. Card. Fail. 17(11), 971–972 (2011).
   Google Scholar
• Markou AL, de Jager MJ, Noyez L. The impact of coronary artery disease on the quality of life of patients undergoing aortic valve replacement. Interact. Cardiovasc. Thorac. Surg. 13(2), 128–132 (2011).
   Google Scholar
• Markou AL, Selten K, Krabbe PF, Noyez L. Quality of life one year post myocardial revascularization and aortic valve replacement in patients aged 70 year or older. J. Cardiovasc. Surg. (Torino) 52(4), 601–607 (2011).
   Google Scholar
• Melsop KA, Boothroyd DB, Hlatky MA. Quality of life and time trade-off utility measures in patients with coronary artery disease. Am. Heart J. 145(1), 36–41 (2003).
   Google Scholar
• Ploegmakers MMJ, Viscaal AM, Finch L, Mayo NE, Brophy JM. The disutility of restenosis - The impact of repeat percutaneous coronary intervention on quality of life. Can. J. Cardiol. 26(6), e197–e200 (2010).
   Google Scholar
• Saeed I, Anyanwu AC, Yacoub MH, Amrani M. Subjective patient outcomes following coronary artery bypass using the radial artery: results of a cross-sectional survey of harvest site complications and quality of life. Eur. J. Cardiothorac. Surg. 20(6), 1142–1146 (2001).
   PubMed Web of Science ®Google Scholar
• Stolker JM, Mahoney EM, Safley DM, Pomposelli FB, Yadav JS, Cohen DJ. Health-related quality of life following carotid stenting versus endarterectomy: Results from the SAPPHIRE (Stenting and Angioplasty with Protection in Patients at HIgh Risk for Endarterectomy) trial. JACC Cardiovasc. Interv. 3(5), 515–523 (2010).
   Google Scholar
• Yan B, Lee V, Liu M, Reid C, Yu CM. Variation in health related quality of life improvement after percutaneous coronary intervention. Value Health 15(4), A70 (2012).
   Google Scholar
• Yan B, Liu M, Lee V, Reid C, Yu C. Health related quality of life of elderly patients undergoing percutaneous coronary intervention. Heart Lung and Circulation 20, S34 (2011).
   Google Scholar
• Hallan S, Asberg A, Indredavik B, Wideroe TE. A decision analysis of thrombolytic therapy compared with standard therapy in acute ischaemic stroke. J. Intern. Med. 246(6), 549–559 (1999).
   Google Scholar
• Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13(9), 873–884 (2004).
   PubMed Web of Science ®Google Scholar
• Johnson JA, Pickard AS. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med. Care 38(1), 115–121 (2000).
   PubMed Web of Science ®Google Scholar
• Kaarlola A, Pettila V, Kekki P. Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients. Intensive Care Med. 30(12), 2245–2252 (2004).
   Google Scholar